骨髓间质干细胞在胰腺疾病和糖尿病治疗中的应用
作者:
作者单位:

(哈尔滨医科大学附属第二医院肿瘤内科,哈尔滨 150001)

作者简介:

通讯作者:

中图分类号:

R576

基金项目:


Application of bone marrow mesenchymal stem cells in the treatment of pancreatic diseases and diabetic mellitus
Author:
Affiliation:

(Department of Oncology, Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    胰腺疾病的发病率正在逐年增加,治疗以控制症状为主,但恢复胰腺细胞功能的研究进展缓慢。骨髓间质干细胞(BMSCs)是存在于骨髓中的具有高度自我更新能力和多向分化潜能的干细胞群,具有特殊的生物学特性和肿瘤趋向性。它在治疗胰腺疾病和糖尿病方面的体内外研究成果显著,为干细胞治疗应用于胰腺疾病和糖尿病的临床治疗奠定了理论和实践基础,为此本文综述了BMSCs在此方面的研究进展。

    Abstract:

    The incidence of pancreatic disease is increasing year by year. Current treatments for these diseases are mainly control of symptoms,but there were not enough studies on pancreatic function recovery. Bone marrow mesenchymal stem cells (BMSCs)are a group of stem cells with high self-renewal capacity and multipotent stromal cells that can differentiate into a variety of cell types in bone marrow. The cells have special biological characteristics and tumor tropism. Great achievements have been obtained in vitro and in vivo for pancreatic diseases and diabetes mellitus, and these studies provide a theoretical and practical basis for the application of stem cell therapy. In the article, we reviewed the research progress of BMSCs in this field.

    参考文献
    相似文献
    引证文献
引用本文

姬坤祥,孙儒雅,孙鹏,徐玉清.骨髓间质干细胞在胰腺疾病和糖尿病治疗中的应用[J].中华老年多器官疾病杂志,2018,17(5):397~400

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-05-24
  • 出版日期: